(Re)Appraising Remission in Ulcerative Colitis

被引:0
|
作者
Sood, Ajit [1 ]
Singh, Arshdeep [1 ]
Mahajan, Ramit [1 ]
Midha, Vandana [2 ]
Bernstein, Charles N. [3 ]
Rubin, David T. [4 ]
机构
[1] Dayanand Med Coll & Hosp, Dept Gastroenterol, Ludhiana, Punjab, India
[2] Dayanand Med Coll & Hosp, Dept Internal Med, Ludhiana, Punjab, India
[3] Univ Manitoba, Rady Fac Hlth Sci, IBD Clin & Res Ctr & Sect Gastroenterol, Max Rady Coll Med,Dept Med, Winnipeg, MB, Canada
[4] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Chicago, IL USA
关键词
Clinical remission; endoscopic remission; inflammatory bowel disease; mucosal healing; treatment goals; ulcerative colitis; INFLAMMATORY-BOWEL-DISEASE; QUALITY-OF-LIFE; C-REACTIVE PROTEIN; HEALING MAYO 0; FECAL CALPROTECTIN; MAINTENANCE THERAPY; HISTOLOGICAL REMISSION; CLINICAL REMISSION; 5-AMINOSALICYLIC ACID; ENDOSCOPIC REMISSION;
D O I
10.1093/ibd/izac170
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
As the therapeutic targets in ulcerative colitis (UC) shift from control of symptoms to mucosal healing and prevention of disease complications like disability, colectomy, and cancer, the definition of remission has evolved. The current definition of clinical remission is variable and is determined by the clinical context in which it is being used. This results in skepticism and uncertainty about the true meaning of the term "clinical remission." In this review, the authors reexamine the definition of clinical remission and propose a novel approach to define remission in UC. Lay Summary The current definition of clinical remission in ulcerative colitis (UC) is variable and is determined by the clinical context in which it is being used. In this review, the authors reexamine the definition of clinical remission in UC and propose a novel approach to define remission based on the parameter being assessed.
引用
收藏
页码:1317 / 1326
页数:10
相关论文
共 50 条
  • [31] Sensorineural hearing loss and ulcerative colitis in remission
    Vishal Bodh
    Rajesh Kumar
    Rajesh Sharma
    Brij Sharma
    Amit Sachdeva
    Ramesh Azad
    Indian Journal of Gastroenterology, 2022, 41 : 143 - 148
  • [32] Mesalamine in the treatment and maintenance of remission of ulcerative colitis
    Ham, Maggie
    Moss, Alan C.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2012, 5 (02) : 113 - 123
  • [33] Oral budesonide for induction of remission in ulcerative colitis
    Sherlock, Mary E.
    MacDonald, John K.
    Griffiths, Anne Marie
    Steinhart, A. Hillary
    Seow, Cynthia H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (10):
  • [34] Ulcerative colitis
    Le Berre, Catherine
    Honap, Sailish
    Peyrin-Biroulet, Laurent
    LANCET, 2023, 402 (10401) : 571 - 584
  • [35] Treatment Targets in Ulcerative Colitis: Is It Time for All In, including Histology?
    Wetwittayakhlang, Panu
    Lontai, Livia
    Gonczi, Lorant
    Golovics, Petra A.
    Hahn, Gustavo Druegg
    Bessissow, Talat
    Lakatos, Peter L.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (23)
  • [36] Therapeutic Potential of Proanthocyanidins in Ulcerative Colitis in Remission
    Glabska, Dominika
    Guzek, Dominika
    Galazka, Karolina
    Lech, Gustaw
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [37] Sensorineural hearing loss and ulcerative colitis in remission
    Bodh, Vishal
    Kumar, Rajesh
    Sharma, Rajesh
    Sharma, Brij
    Sachdeva, Amit
    Azad, Ramesh
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2022, 41 (02) : 143 - 148
  • [38] Current approaches for optimizing the benefit of biologic therapy in ulcerative colitis
    Sofia, M. Anthony
    Rubin, David T.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (04) : 548 - 559
  • [39] Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn's Disease Phenotypes
    Taleban, Sasha
    Stewart, Kathleen O.
    Li, Darrick K.
    Singh, Prashant
    Pardi, Darrell S.
    Sturgeon, Holly C.
    Yajnik, Vijay
    Xavier, Ramnik J.
    Ananthakrishnan, Ashwin N.
    Khalili, Hamed
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (09) : 2627 - 2635
  • [40] Early Clinical Remission Is a Predictor of Long-Term Remission with the Use of Vedolizumab for Ulcerative Colitis
    Haga, Keiichi
    Shibuya, Tomoyoshi
    Osada, Taro
    Sato, Shunsuke
    Fukuo, Yuka
    Kobayashi, Osamu
    Yamada, Toshio
    Asaoka, Daisuke
    Ito, Kentaro
    Nomura, Kei
    Haraikawa, Mayuko
    Nomura, Osamu
    Fukushima, Hirofumi
    Murakami, Takashi
    Ishikawa, Dai
    Hojo, Mariko
    Nagahara, Akihito
    BIOMEDICINES, 2022, 10 (10)